An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
2020 · New England Journal of Medicine · 3,422 citations
https://doi.org/10.1056/nejmoa2022483
E
Evan J. Anderson
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
468
Papers
33.6K
Citations
75
h-index
219
i10-index
Evan J. Anderson is an academic researcher from Emory University. The author has contributed to research in topics: Respiratory viral infections research & SARS-CoV-2 and COVID-19 Research & Influenza Virus Research Studies. The author has an h-index of 75, co-authored 398 publications.
ORCID: 0000-0002-1576-4420Papers by this author
worksRapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
2020 · Cell Reports Medicine · 541 citations
https://doi.org/10.1016/j.xcrm.2020.100040
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
2017 · Clinical Infectious Diseases · 234 citations
https://doi.org/10.1093/cid/cix317
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
2022 · New England Journal of Medicine · 170 citations
https://doi.org/10.1056/nejmoa2203315
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
2022 · New England Journal of Medicine · 136 citations
https://doi.org/10.1056/nejmoa2209367
Influenza-Related Hospitalizations and Poverty Levels — United States, 2010–2012
2016 · MMWR Morbidity and Mortality Weekly Report · 80 citations
https://doi.org/10.15585/mmwr.mm6505a1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat